admin

11/9/2012 - Slower Growth Seen in a Graying World

As the world grows older in the coming decades, economic growth will slow. That forecast was issued Friday by the Organization for Economic Cooperation and Development, a group of 34 countries that includes all of the major industrialized nations. Read the full article at The New York Times.

11/8/12 – 401(k) Balances Hit Record High

401(k) balances are hitting record highs as employees stash away bigger shares of their salaries and companies ramp up contributions. The average 40(k) balance climbed to $75,900 at the end of the third quarter, according to Fidelity Investments, the biggest 401(k) provider in the country. That’s the highest level the firm has seen since it… Read more 11/8/12 – 401(k) Balances Hit Record High

11/1/12 – Center for Retirement Research Updates National Retirement Risk Index

The brief’s key findings are: The National Retirement Risk Index (NRRI), based on newly released Survey of Consumer Finances data, shows that over half of households may be unable to maintain their standard of living in retirement. Between 2007 and 2010, the NRRI jumped by 9 percentage points due to: the bursting of the housing… Read more 11/1/12 – Center for Retirement Research Updates National Retirement Risk Index

William F. Sharpe, PhD STANCO 25 Professor of Finance, Emeritus Lee Ross, PhD Stanford Federal Credit Union Professor of Psychology Ian Gotlib, PhD Albert A. Lang Professor of Psychology; Senior Associate Dean for the Social Sciences in Humanities and Sciences

10/30/2012 - The Risks of Tapping Your Retirement Fund for an Alternative Use

Retirement funds are being used increasingly for anything but retirement. Instead, 401(k)’s and individual retirement accounts are becoming money pots used to invest in business start-ups, speculate in gold and buy private equity investments. Such maneuvers come with big tax advantages. But they may also leave their users penniless in retirement, while their ability to… Read more 10/30/2012 - The Risks of Tapping Your Retirement Fund for an Alternative Use

10/29/2012 - Lilly trials boost amyloid link to Alzheimer's-analysis

Levels of a protein believed to be a main cause of Alzheimer’s disease rose in the blood of patients treated with Eli Lilly’s experimental drug in late-stage trials, suggesting the protein, beta amyloid, was removed from the brain as intended, researchers said on Monday. Read the full article at Reuters.

10/29/2012 - How Cannabinoids May Slow Brain Aging

Since the mid 2000′s researchers have been building an appreciation for the power of marijuana-like substances that make up the brain’s cannabinoid systems. In animal experiments, for example, synthetic compounds similar to THC—marijuana’s main psychoactive component—have shown promise in preserving brain functions. A 2008 study even demonstrated that a THC-like substance reduced brain inflammation and… Read more 10/29/2012 - How Cannabinoids May Slow Brain Aging

Gopi Shah Goda

Senior Research Scholar and Postdoctoral Fellow Program Coordinator, Stanford Institute for Economic Policy Research (SIEPR) Research interests: Public Finance, Health Economics, Applied Microeconomics,Labor Economics, Economic Demography, Actuarial Science Email: gopi@stanford.edu Phone: (650) 736-0480 Address: Stanford Institute for Economic Policy Research (SIEPR) Stanford University 366 Galvez Street Stanford, CA 94305-6015  Website: http://www.stanford.edu/~gopi/index.html  

Hazel Markus

Davis-Brack Professor in the Behavioral Sciences Research interests: Sociocultural shaping of mind and self; how gender, ethnicity, religion, social class, cohort, or region or country of national origin may influence thought and feeling, particularly self-relevant thought and feeling; similarities and differences in the nature of self-concept and in the functioning of self-esteem; age and cohort variation… Read more Hazel Markus

Marcia Stefanick

Professor (Research) of Medicine (Stanford Prevention Research Center) and of Obstetrics and Gynecology Research interests: Chronic disease prevention (particularly, heart disease, breast cancer, osteoporosis, and dementia) in both women and men; the effects of menopausal hormones on cardiovascular and other health outcomes in mostly healthy postmenopausal women (in the Womens Health Initiative, WHI), in women with established… Read more Marcia Stefanick